Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Spotlight on... dermatitis herpetiformis

This month’s spotlight on coincides with our dermatology focus, exploring the symptoms and treatments of dermatitis herpetiformis, a skin manifestation of coeliac disease. Our latest ‘spotlight on’ takes a look at a skin condition that is caused by coeliac disease, called dermatitis herpetiformis. Coeliac disease is not...

Articles

Taking medical innovation to the next level

Greg Kueterman from Eli Lilly and Company shares his thoughts on the importance of advancing pharma R&D innovation, in the first of many articles by Lilly for pharmaphorum. Advancing medical innovation has never been more important than it is today. The number of people globally with...

Articles

What doctors think about industry involvement in peer-review...

The open publishing of clinical trial data is a hot topic at the moment, but does everyone agree with the change? Tom Rees discusses. Research is the bedrock of the pharmaceutical industry. For new treatments to be adopted as part of medical practice, it is critically...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital